论文部分内容阅读
近年来,用干扰素治疗呼吸道合胞病毒性肺炎取得较好疗效,现将100例病儿应用结果报告如下。1 临床资料选择100例呼吸道合胞病毒肺炎病儿为观察对象,病例选择条件:年龄6个月～2岁,病程小于1周。临床以喘憋为主要症状,血常规:白细胞10×10~9/L,淋巴细胞大于0.60。X 线表现主要以肺纹理增粗及肺气肿、散在点片状阴影。用免疫荧光法检测呼吸道脱落的柱状上皮细胞合胞病毒抗原结果阳性。抗感染均用氨苄青霉素,在对症支持疗法相同情况下,随机分为二组。干扰素由沈阳市康利制药厂生产的人白细胞干扰素,5万
In recent years, the use of interferon in the treatment of respiratory syncytial virus pneumonia achieved good effect, now 100 cases of sick children report the results as follows. 1 Clinical data Select 100 cases of respiratory syncytial virus pneumonia in children as the observation object, case selection conditions: age 6 months to 2 years, duration of less than 1 week. Clinical asthma as the main symptom, routine blood: white blood cells 10 × 10 ~ 9 / L, lymphocytes greater than 0.60. X-ray findings mainly to the lungs texture thickening and emphysema, scattered at the sheet-like shadow. Immunofluorescence was used to detect respiratory syncytial antigen of columnar epithelial cells syncytial virus. Anti-infection with ampicillin, symptomatic and supportive care in the same circumstances, were randomly divided into two groups. Interferon from Shenyang Pharmaceutical Factory production of human leukocyte interferon, 50,000